n | % | |
---|---|---|
Sex | ||
Male | 39 | 56.5 |
Female | 30 | 43.5 |
Age | ||
mean (range) | 84 | 66–99 |
65–80 | 20 | 29.0 |
> 80 | 49 | 71.0 |
Presentation | ||
Initial diagnosis | 26 | 37.7 |
Local recurrence | 30 | 43.5 |
Nodal recurrence | 13 | 18.8 |
T stage | ||
T1 | 11 | 15.9 |
T2 | 6 | 8.7 |
T3 | 14 | 20.3 |
T4 | 5 | 7.2 |
n/a | 33 | 47.83 |
N stage | ||
N0 | 23 | 33.3 |
N1 | 4 | 5.8 |
N2 | 10 | 14.5 |
N3 | 1 | 1.4 |
n/a | 31 | 44.9 |
M stage | ||
M0 | 23 | 33.3 |
M1 | 4 | 5.8 |
Mx | 6 | 8.7 |
n/a | 36 | 52.2 |
Grading | ||
G1 | 6 | 8.7 |
G2 | 35 | 50.7 |
G3 | 19 | 27.5 |
n/a | 9 | 13.0 |
R-status (if adjuvant) | ||
R0 | 5 | 22.7 |
Rx | 3 | 13.6 |
R1 | 10 | 45.5 |
R2 | 2 | 9.1 |
n/a | 2 | 9.1 |
KPS | ||
Median (range) | 80% | (40–100%) |
100–90% | 17 | 24.6 |
80–70% | 38 | 55.0 |
60–50% | 8 | 11.6 |
< 50% | 3 | 4.3 |
n/a | 3 | 4.3 |
CCI | ||
Median (range) | 6 | (2–10) |
≤ 4 | 16 | 23.2 |
5 | 15 | 21.7 |
6 | 19 | 27.5 |
7 | 17 | 24.6 |
≥ 8 | 2 | 2.9 |